assets to be divested by the Company. Therefore, the Company will obtain the approval for the asset disposal transactions in accordance with the business restructuring plan of the Company as outlined in
credibility of the Thai capital market as a whole; (4) the offer for sale of securities may cause [i] any damage or [ii] an unfair treatment to the investors as a whole or [iii] the investors not to obtain
issued ordinary shares at the Extraordinary General Meeting of Shareholders No. 1/2017, the Company must obtain an approval from the SEC to offer the newly issued ordinary shares to the specific investor
shares of HECH and newly issued shares of GS will allow the Company to acquire shares of GS directly and indirectly total of 46.00% of the total paid-up capital of GS (This amount is included the amount of
is a subsidiary of the Company, on Letter of Intention “LOI” to acquire franchise from Wuttisak Clinic Inter. Group Co., Ltd. (“WCIG”), ”), which is an indirect subsidiary of E FOR L AIM Public Co
Center Co., Ltd. (“HHC”), which is a subsidiary of the Company, on Letter of Intention “LOI” to acquire franchise from Wuttisak Clinic Inter. Group Co., Ltd. (“WCIG”), ”), which is an indirect subsidiary
Public Company Limited (“IVL” or the “Company”) held on 11 th May 2018, has approved Indorama Netherlands B.V. its indirect subsidiary to further acquire 24 % equity stake in PT. Indorama Petrochemicals, a
further acquire the remaining 26% equity stake in PT. Indorama Petrochemicals (“PTIP”), a PTA manufacturing plant in Indonesia from PT. Indo-Rama Synthetics Tbk., a connected party. Rationale of the
for this Investment is from the capital increase of Oventure Pte. Ltd. and the Company will utilize such fund to acquire the maximum amount of shares up to 26% in BCB (i.e. acquisition of new shares up